
Natco Pharma Limited has informed the Exchange regarding a press release dated August 29, 2024, titled "Submission of Abbrevated New Drug Application (ANDA).
Filed with NSE ·

Natco Pharma Limited has informed the Exchange regarding a press release dated August 29, 2024, titled "Submission of Abbrevated New Drug Application (ANDA).
6ix hasn’t read this filing yet.
Follow NATCO Pharma into a list and get an email when it puts out news.
Follow NATCO Pharma